Mitchell Lazar (born 1956) is an endocrinologist and physician-scientist known for his discovery of the hormone resistin[1] and his contributions to the transcriptional regulation of metabolism.
Lazar graduated from Syosset High School,[citation needed] and three years later received his undergraduate degree in chemistry from the Massachusetts Institute of Technology, then received a PhD in Neurosciences and an MD from Stanford University.
Lazar's research focus is on the epigenomic regulation of gene expression and metabolism.
Lazar's findings relate to the basic mechanisms of nuclear receptor action and their role in obesity and diabetes, most notably the discovery of the hormone resistin.
[2] Lazar is a former member of the Board of Scientific Councilors of the National Institutes of Diabetes, Digestive, and Kidney Diseases.